Compositions, kits and methods for ameliorating oculoplastic post-procedural effects
US11260094B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 6, 2018 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Aug 13, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention are directed to compositions, kits and methods for minimizing unsightly post-procedural effects associated with an oculoplastic procedure. The composition can include escin, arnica and phytonadione in a pharmacologically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.